tert-Butyl (S)-4-benzyl-2-(2-hydroxyethyl)piperazine-1-carboxylate hydrochloride
95%
- Product Code: 38537
CAS:
2453297-16-8
| Molecular Weight: | 356.8875 g./mol | Molecular Formula: | C₁₈H₂₉ClN₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28411283 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the production of various therapeutic agents, including those targeting central nervous system disorders. Its structural features, such as the piperazine ring and benzyl group, make it valuable for designing compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, it is employed in the preparation of prodrugs or active pharmaceutical ingredients (APIs) that require specific stereochemistry for enhanced efficacy. Its hydrochloride form improves solubility, making it suitable for formulation studies and preclinical testing.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | $448.42 |
+
-
|
tert-Butyl (S)-4-benzyl-2-(2-hydroxyethyl)piperazine-1-carboxylate hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the production of various therapeutic agents, including those targeting central nervous system disorders. Its structural features, such as the piperazine ring and benzyl group, make it valuable for designing compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, it is employed in the preparation of prodrugs or active pharmaceutical ingredients (APIs) that require specific stereochemistry for enhanced efficacy. Its hydrochloride form improves solubility, making it suitable for formulation studies and preclinical testing.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :